CAS: 1044871-04-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RVX-297 REF: IN-DA01X6ZLCAS: 1044871-04-6 | 98% | To inquire | Tue 10 Dec 24 |
 | RVX-297 REF: TM-T28628CAS: 1044871-04-6 | 98.11% | 49.00 €~792.00 € | Mon 16 Dec 24 |
 | RVX-297 REF: 3D-URB87104CAS: 1044871-04-6 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA01X6ZL
| 1g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
RVX-297
CAS:1044871-04-6
RVX-297 selectively inhibits BD2 domains of BET bromodomains, binding preferentially to BET proteins.
Formula:
C24H29N3O4
Purity:
98.11%
Color and Shape:
Solid
Molecular weight:
423.5
Ref: TM-T28628
| 1mg | 49.00 € | ||
| 5mg | 95.00 € | ||
| 10mg | 157.00 € | ||
| 25mg | 305.00 € | ||
| 50mg | 491.00 € | ||
| 100mg | 792.00 € | ||
| 1mL*10mM (DMSO) | 104.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
RVX-297
CAS:1044871-04-6
RVX-297 is a medicinal analog that has been developed as an anticancer agent. It works …
Formula:
C24H29N3O4
Purity:
Min. 95%
Molecular weight:
423.5 g/mol
Ref: 3D-URB87104
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
